Vanguard Group Inc Chimerix Inc Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Chimerix Inc stock. As of the latest transaction made, Vanguard Group Inc holds 4,044,877 shares of CMRX stock, worth $19.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,044,877
Previous 4,330,398
6.59%
Holding current value
$19.2 Million
Previous $4.03 Million
249.54%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CMRX
# of Institutions
77Shares Held
40.3MCall Options Held
243KPut Options Held
110K-
Ra Capital Management, L.P. Boston, MA8.8MShares$41.7 Million0.5% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.77MShares$17.9 Million0.32% of portfolio
-
Monaco Asset Management Sam2.82MShares$13.4 Million1.45% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.56MShares$12.1 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$10.6 Million0.11% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $415M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...